Overnight Trade Opportunity Next Week?!
I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!
Go Here to Join.
pixel

LUMO Insider Trading (Lumos Pharma)

Insider Ownership Percentage: 17.50%
Insider Buying (Last 12 Months): $1,949,462.70
Insider Selling (Last 12 Months): $3,029,079.44

Lumos Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Lumos Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lumos Pharma Share Price & Price History

Current Price: $9.90
Price Change: Price Decrease of -0.26 (-2.56%)
As of 09/27/2021 01:00 AM ET

This chart shows the closing price history over time for LUMO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Overnight Trade Opportunity Next Week?!
I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!
Go Here to Join.
pixel

Lumos Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/7/2021Kevin M. LalandeDirectorBuy10,000$11.11$111,100.00View SEC Filing Icon  
9/3/2021Kevin M. LalandeDirectorBuy8,100$11.35$91,935.00View SEC Filing Icon  
9/1/2021Kevin M. LalandeDirectorBuy4,589$10.87$49,882.43View SEC Filing Icon  
8/30/2021Kevin M. LalandeDirectorBuy8,625$10.52$90,735.00View SEC Filing Icon  
8/27/2021Kevin M. LalandeDirectorBuy4,981$10.50$52,300.50View SEC Filing Icon  
8/25/2021Kevin M. LalandeDirectorBuy14,900$9.87$147,063.00View SEC Filing Icon  
8/23/2021Kevin M. LalandeDirectorBuy37,800$9.58$362,124.00View SEC Filing Icon  
8/20/2021Kevin M. LalandeDirectorBuy35,679$8.73$311,477.67View SEC Filing Icon  
8/18/2021Kevin M. LalandeDirectorBuy28,870$8.73$252,035.10View SEC Filing Icon  
8/16/2021Kevin M. LalandeDirectorBuy31,000$7.96$246,760.00View SEC Filing Icon  
8/12/2021Kevin M. LalandeDirectorBuy31,000$7.55$234,050.00View SEC Filing Icon  
1/8/2021James E FlynnMajor ShareholderSell106,512$22.31$2,376,282.72View SEC Filing Icon  
1/6/2021James E FlynnMajor ShareholderSell29,039$22.48$652,796.72View SEC Filing Icon  
See Full Table
Insider Selling at Lumos Pharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Lumos Pharma and related companies.

SEC Filings (Institutional Ownership Changes) for Lumos Pharma (NASDAQ:LUMO)

38.36% of Lumos Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LUMO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Lumos Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/17/2021Wells Fargo & Company MN215,958$2.16M0.0%+30.0%2.584%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD159,595$1.59M0.0%N/A1.910%Search for SEC Filing on Google Icon
8/16/2021Opaleye Management Inc.382,000$3.82M0.6%+1.4%4.571%Search for SEC Filing on Google Icon
8/16/2021State Street Corp11,237$0.11M0.0%N/A0.134%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC305,757$3.06M0.0%-8.0%3.659%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP39,405$0.39M0.0%-5.0%0.472%Search for SEC Filing on Google Icon
8/12/2021Connor Clark & Lunn Investment Management Ltd.31,938$0.32M0.0%-4.1%0.382%Search for SEC Filing on Google Icon
7/19/2021Marquette Asset Management LLC8,919$89K0.0%N/A0.107%Search for SEC Filing on Google Icon
5/18/2021Opaleye Management Inc.376,900$4.41M0.6%+34.0%4.516%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C373,117$4.37M0.1%-60.1%4.471%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP41,459$0.49M0.0%-4.8%0.497%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC332,419$3.89M0.0%+7.6%3.983%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp2,960$35K0.0%-75.5%0.035%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC5,879$69K0.0%+65.0%0.070%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.71,078$0.83M0.0%+2.9%0.853%Search for SEC Filing on Google Icon
4/14/2021Investors Financial Group LLC29,200$0.34M0.2%+60.4%0.350%Search for SEC Filing on Google Icon
2/22/2021West Financial Advisors LLC784$28K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2021Verition Fund Management LLC9,835$0.35M0.0%N/A0.119%Search for SEC Filing on Google Icon
2/16/2021One68 Global Capital LLC5,855$0.21M0.4%N/A0.071%Search for SEC Filing on Google Icon
2/16/2021ExodusPoint Capital Management LP37,203$1.33M0.0%N/A0.448%Search for SEC Filing on Google Icon
2/12/2021Opaleye Management Inc.281,287$10.05M1.3%+16.8%3.390%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp12,081$0.43M0.0%+292.0%0.146%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC308,812$11.03M0.0%+0.9%3.722%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN117,660$4.20M0.0%+1.1%1.418%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp17,493$0.63M0.0%N/A0.211%Search for SEC Filing on Google Icon
1/21/2021Foster Group Inc.7,283$0.22M0.0%N/A0.088%Search for SEC Filing on Google Icon
1/19/2021Investors Financial Group LLC18,200$0.65M0.4%-16.4%0.219%Search for SEC Filing on Google Icon
11/12/2020Connor Clark & Lunn Investment Management Ltd.31,978$0.44M0.0%-12.5%0.386%Search for SEC Filing on Google Icon
11/10/2020Texas Yale Capital Corp.16,000$0.22M0.0%+6.7%0.193%Search for SEC Filing on Google Icon
11/9/2020Acadian Asset Management LLC5,161$71K0.0%-85.7%0.062%Search for SEC Filing on Google Icon
11/5/2020Wells Fargo & Company MN116,392$1.61M0.0%+3.7%1.403%Search for SEC Filing on Google Icon
10/14/2020Investors Financial Group LLC21,766$0.30M0.2%-81.1%0.262%Search for SEC Filing on Google Icon
9/15/2020Two Sigma Advisers LP13,298$0.22M0.0%-5.0%0.160%Search for SEC Filing on Google Icon
8/14/2020Logos Global Management LP50,000$0.83M0.2%N/A0.606%Search for SEC Filing on Google Icon
8/14/2020Jefferies Group LLC120,651$1.99M0.0%+13.0%1.462%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Lumos Pharma logo
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.
Read More on Lumos Pharma

Today's Range

Now: $9.90
Low: $9.69
High: $10.11

50 Day Range

MA: $9.30
Low: $7.36
High: $11.36

52 Week Range

Now: $9.90
Low: $7.23
High: $36.72

Volume

14,366 shs

Average Volume

52,243 shs

Market Capitalization

$82.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.74

Who are the company insiders with the largest holdings of Lumos Pharma?

Lumos Pharma's top insider shareholders include:
  1. James E Flynn (Major Shareholder)
  2. Kevin M Lalande (Director)

Who are the major institutional investors of Lumos Pharma?

Lumos Pharma's top institutional shareholders include:
  1. Opaleye Management Inc. — 4.57%
  2. Renaissance Technologies LLC — 3.66%
  3. Wells Fargo & Company MN — 2.58%
  4. Price T Rowe Associates Inc. MD — 1.91%
  5. Dimensional Fund Advisors LP — 0.47%
  6. Connor Clark & Lunn Investment Management Ltd. — 0.38%

Which major investors are selling Lumos Pharma stock?

In the last quarter, LUMO stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Dimensional Fund Advisors LP
  3. Connor Clark & Lunn Investment Management Ltd.

Which major investors are buying Lumos Pharma stock?

In the previous quarter, LUMO stock was purchased by institutional investors including:
  1. Price T Rowe Associates Inc. MD
  2. Wells Fargo & Company MN
  3. State Street Corp
  4. Marquette Asset Management LLC
  5. Opaleye Management Inc.
Overnight Trade Opportunity Next Week?!
I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!
Go Here to Join.
pixel